6Latent Space (swyx)·
Midjourney announces medical imaging product as second major offering
Midjourney, notable as a bootstrapped frontier AI lab, has announced a medical imaging product described as enabling organ scanning with the ease of stepping on a scale. This represents the company's second product beyond its flagship image generation offering. The move signals Midjourney's expansion into medical AI, a significant strategic pivot for the image-generation-focused company.
Related guides (2)
Related events (8)
ClinFusion: Vision-centric multimodal LLM for holistic medical image understanding
Researchers introduce ClinFusion, a multimodal LLM system designed for clinical medical understanding, featuring a cascaded vision encoder architecture (Cascade Spatial-Aware Locality Fusion) that handles both 2D and native 3D medical images within a unified encoder. The system is evaluated on a new benchmark suite including MedIF-Bench and a region-of-interest-grounded report generation metric, claiming state-of-the-art results on 20 of 24 benchmarks against open-source medical MLLMs and outperforming GPT-5.2 and Gemini-3-Flash on 13 of 16 multimodal benchmarks. Blinded evaluation by board-certified radiologists confirms ClinFusion produces the highest-ranked radiology reports, and the proposed RoI-grounded metric shows the strongest correlation with expert judgment among automatic metrics tested.
Microsoft Build recap: MAI-Thinking-1 and MAI Family models announced
Microsoft unveiled MAI-Thinking-1 and the broader MAI family of models at Microsoft Build 2026, as covered in the Latent Space AINews recap. The announcement represents Microsoft's push into frontier reasoning models under its own brand, distinct from its OpenAI partnership. Technical details of the MAI model family are discussed, signaling a significant strategic move toward Microsoft-native AI model development.
DeepMind Brings AI Image Verification to the Gemini App
DeepMind is integrating AI image verification capabilities directly into the Gemini app, enabling users to assess the authenticity or provenance of images. The feature likely leverages content credentials or watermarking techniques to surface metadata about AI-generated or manipulated images. This represents a practical deployment of provenance and authenticity tooling within a major consumer AI product.
Personal account: using Claude Code to analyze MRI scans as a medical second opinion
A personal blog post describes using Claude Code (with Claude Opus 4.8 implied) to analyze MRI scan results as an informal second opinion. The post attracted significant Hacker News engagement (257 points, 365 comments), suggesting broad community interest in AI-assisted medical interpretation. The case illustrates both the practical appeal and the safety/reliability questions around using frontier LLMs for personal medical decision-making.
Orakl Oncology uses Meta's DINOv2 to accelerate cancer organoid analysis and drug response prediction
Orakl Oncology, a spinoff from the Gustave Roussy Institute, has deployed Meta's open-source DINOv2 vision model to analyze cancer organoid images and predict patient drug responses in clinical trials. In collaboration with CentraleSupelec and the Jaulin Lab under the RHU ORGANOMIC initiative, the team found DINOv2 outperformed prior specialized models by 26.8% accuracy. The model enabled quantitative extraction of imaging data from organoid videos, replacing labor-intensive frame-by-frame analysis and significantly accelerating their biomedical platform development.
MedGemma: DeepMind releases most capable open models for health AI development
Google DeepMind has announced new multimodal models in the MedGemma collection, described as their most capable open models for health AI development. The release expands the MedGemma family with enhanced multimodal capabilities targeting medical and clinical AI applications. As open models, they are intended to support developers building health AI systems.
AI-Native Healthcare: Abridge on 100M Doctor Visits, Clinician Time Savings, and Prior Auth Automation
Latent Space interviews Abridge co-founders Janie Lee and Chai Asawa about their AI-native healthcare platform that has processed 100 million doctor visits. The system converts patient-clinician conversations into structured clinical documentation, reportedly saving clinicians 10-20 hours per week. The platform also automates prior authorization workflows, reducing turnaround from days to minutes.
OpenAI Invests in Merge Labs for Brain-Computer Interface Development
OpenAI has announced an investment in Merge Labs, a company focused on brain-computer interfaces (BCIs) that aim to bridge biological and artificial intelligence. The stated goal is to maximize human ability, agency, and experience through direct neural-AI integration. This represents OpenAI's continued expansion into hardware and human-AI interface technologies beyond software.